Haroun Gajraj: How Much of a Problem are Brown Marks after Sclerotherapy, Really?
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn:
“Brown marks after sclerotherapy – How much of a problem is it really?
In my experience some degree of brown discolouration after sclerotherapy is ineviteble
So what should we tell our patients?
Should we avoid sclerotherapy in the summer?
Earlier in the week I met up with Louise Evans
She is learning all about Microsclerotherapy and wondered whether she had over-emphasised post-sclerotherapy pigmentation as a complication. And the consequence?
She was seeing lots of people interested in sclerotherapy for leg spider veins but nobody was booking for treatment until the autumn
Here’s what I told her
- What’s your approach to sclerotherapy?
- Do you avoid it in the summer?
- Do you use sunblocks?
- When you get pigmentation, how do you manage it?
Clarification: In this video I say that the UK has more convertibles than Mediterranean countries.
More precisely, the UK has historically been one of Europe’s strongest markets for convertibles – especially relative to our cloudy climate – but robust, up‑to‑date data comparing the exact percentage of convertibles in each country’s car fleet are limited.
So it’s more accurate to say the UK is unusually ‘convertible‑heavy’ for such a grey country, rather than definitively ahead of every Mediterranean nation.
I’m interested to know what my colleagues in the UK do…”
Proceed to the video attached to the post.
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support